Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions unit in a $17.5 billion deal.

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider Becton Dickinson in a stock-and-cash transaction valued at $17.5 billion, expanding its scale in clinical and diagnostic applications.

BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through a transaction valued at $17.5 billion that ranks it as one of | For 2025, the to-be-combined company’s portfolios and its 16,